Augmented least squares, a powerful chemometric approach for the spectroscopic analysis of the antiretroviral therapy abacavir, lamivudine and dolutegravir in their ternary mixture

被引:4
作者
Alqahtani, Ali [1 ]
Abdelazim, Ahmed H. [2 ]
Alqahtani, Taha [1 ]
Gahtani, Reem M. [3 ]
Serag, Ahmed [2 ]
机构
[1] King Khalid Univ, Coll Pharm, Dept Pharmacol, Abha 62529, Saudi Arabia
[2] Al Azhar Univ, Fac Pharm, Pharmaceut Analyt Chem Dept, Cairo 11751, Egypt
[3] King Khalid Univ, Coll Appl Med Sci, Dept Clin Lab Sci, Abha 61421, Saudi Arabia
关键词
Spectroscopy; Chemometrics; CRACLS; SRACLS; Antiretroviral therapy; HIV;
D O I
10.1016/j.saa.2023.123710
中图分类号
O433 [光谱学];
学科分类号
0703 ; 070302 ;
摘要
Augmented least squares models such as concentration residual augmented classical least squares (CRACLS) and spectral residual augmented classical least squares (SRACLS) are powerful chemometric approaches that can be applied for spectroscopic analysis of many pharmaceutical compounds. Herein, both CRACLS and SRACL have been employed for UV spectral analysis of three antiretroviral therapy namely abacavir (ACV), lamivudine (LMV) and dolutegravir (DTG) in their ternary mixture. A partial factorial design has been utilized for calibration set construction then both CRACLS and SRACLS models have been optimized regarding the number of iterations and principal components, respectively, using a leave-one-out cross-validation procedure. It was found that a higher number of iterations and principal components were required for modelling the minor component DTG indicating more augmentation procedures to improve the models' accuracy. Validation of the proposed models was performed using external validation set of 13 mixtures and different validation parameters have been evaluated regarding models' predictive abilities. Both models showed excellent performance for analyzing ACV and LMV with relative root mean square error of prediction (RRMSEP) below 2 %. However, higher RRMSEP values around 5 % were observed for the minor component DTG suggesting that these models should be utilized with caution when analyzing minor components in mixtures. Furthermore, the suggested models have been applied for analyzing ACV, LMV and DTG in their pharmaceutical formulation and excellent agreement was observed between the suggested models and the reported chromatographic method posing these models as powerful chemometric approaches for quality control analysis of many pharmaceutical compounds.
引用
收藏
页数:5
相关论文
共 21 条
[1]   Different spectrophotometric methods applied for the analysis of simeprevir in the presence of its oxidative degradation product: Acomparative study [J].
Attia, Khalid A. M. ;
El-Abasawi, Nasr M. ;
El-Olemy, Ahmed ;
Serag, Ahmed .
SPECTROCHIMICA ACTA PART A-MOLECULAR AND BIOMOLECULAR SPECTROSCOPY, 2018, 190 :1-9
[2]   Firefly algorithm versus genetic algorithm as powerful variable selection tools and their effect on different multivariate calibration models in spectroscopy: A comparative study [J].
Attia, Khalid A. M. ;
Nassar, Mohammed W. I. ;
El-Zeiny, Mohamed B. ;
Serag, Ahmed .
SPECTROCHIMICA ACTA PART A-MOLECULAR AND BIOMOLECULAR SPECTROSCOPY, 2017, 170 :117-123
[3]   Stability indicating methods for the analysis of cefprozil in the presence of its alkaline induced degradation product [J].
Attia, Khalid A. M. ;
Nassar, Mohammed W. I. ;
El-Zeiny, Mohamed B. ;
Serag, Ahmed .
SPECTROCHIMICA ACTA PART A-MOLECULAR AND BIOMOLECULAR SPECTROSCOPY, 2016, 159 :1-6
[4]   Zero order and signal processing spectrophotometric techniques applied for resolving interference of metronidazole with ciprofloxacin in their pharmaceutical dosage form [J].
Attia, Khalid A. M. ;
Nassar, Mohammed W. I. ;
El-Zeiny, Mohamed B. ;
Serag, Ahmed .
SPECTROCHIMICA ACTA PART A-MOLECULAR AND BIOMOLECULAR SPECTROSCOPY, 2016, 154 :232-236
[5]   Multilevel multifactor designs for multivariate calibration [J].
Brereton, RG .
ANALYST, 1997, 122 (12) :1521-1529
[6]   Current status and prospects of HIV treatment [J].
Cihlar, Tomas ;
Fordyce, Marshall .
CURRENT OPINION IN VIROLOGY, 2016, 18 :50-56
[7]   Combination dolutegravir-abacavir-lamivudine in the management of HIV/AIDS: clinical utility and patient considerations [J].
Cruciani, Mario ;
Malena, Marina .
PATIENT PREFERENCE AND ADHERENCE, 2015, 9 :299-310
[8]   Abacavir plus lamivuldine - A review of their combined use in the management of HIV infection [J].
Dando, TM ;
Scott, LJ .
DRUGS, 2005, 65 (02) :285-302
[9]  
Dong MW, 2013, LC GC N AM, V31, P472
[10]  
Dubey S., 2018, Int. J. App. Pharm, V10, P46, DOI 10.22159/ijap.2018v10i1.21156